Renovacor 

$3.2
4
+$0.15+4.92% Wednesday 21:00

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
55.26M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

7AugExpected
Q4 2021
Q1 2022
Q2 2022
Q3 2022
Q4 2022
Q1 2023
Q2 2023
-0.87
-0.46
-0.05
0.36
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RCOR. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Renovacor is a preclinical stage gene therapy company developing a pipeline of innovative and proprietary AAV-based gene therapies for BAG3 gene mutation-associated diseases in areas of high unmet medical need. Renovacor’s therapeutic focus is initially on cardiovascular disease, with a lead program in BAG3 mutation-associated dilated cardiomyopathy.
Show more...
CEO
Employees
2
Country
US
ISIN
US75989E1064

Listings

0 Comments

Share your thoughts

FAQ

What is Renovacor stock price today?
The current price of RCOR is $3.2 USD — it has increased by +4.92% in the past 24 hours. Watch Renovacor stock price performance more closely on the chart.
What is Renovacor stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Renovacor stocks are traded under the ticker RCOR.
What is Renovacor market cap?
Today Renovacor has the market capitalization of 55.26M
How many employees does Renovacor have?
As of April 01, 2026, the company has 2 employees.
In which sector is Renovacor located?
Renovacor operates in the Professional, Scientific, and Technical Services sector.
When did Renovacor complete a stock split?
Renovacor has not had any recent stock splits.